Phase I Study of GW856553 (Losmapimod)

NCT01648192 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Coronary Syndrome

Interventions

DRUG: Losmapimod for single dose
DRUG: Losmapimod for repeat dose

Sponsor

GlaxoSmithKline